Methadone
Methadone is a valuable opioid in the management of patients who have cancer with pain. Methadone is a mu-, kappa-, and delta-opioid agonist, and an N-methyl- D -aspartate receptor antagonist. These mechanisms of action make methadone an attractive option for complex pain syndromes. It is critically...
Saved in:
Published in: | Hematology/oncology clinics of North America Vol. 32; no. 3; pp. 405 - 415 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
Elsevier Inc
01-06-2018
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Methadone is a valuable opioid in the management of patients who have cancer with pain. Methadone is a mu-, kappa-, and delta-opioid agonist, and an N-methyl- D -aspartate receptor antagonist. These mechanisms of action make methadone an attractive option for complex pain syndromes. It is critically important that providers consider a patient’s risk status before beginning methadone. Careful consideration must be given to dosing methadone in both opioid-naïve and opioid-tolerant patients, with vigilant monitoring for therapeutic effectiveness and potential toxicity until the patient achieves steady state. |
---|---|
AbstractList | Methadone is a valuable opioid in the management of patients who have cancer with pain. Methadone is a mu-, kappa-, and delta-opioid agonist, and an N-methyl-D-aspartate receptor antagonist. These mechanisms of action make methadone an attractive option for complex pain syndromes. It is critically important that providers consider a patient’s risk status before beginning methadone. Careful consideration must be given to dosing methadone in both opioid-naïve and opioid-tolerant patients, with vigilant monitoring for therapeutic effectiveness and potential toxicity until the patient achieves steady state. |
Author | McPherson, Alexandra L., PharmD, MPH Costantino, Ryan C., PharmD, BCPS, BCGP McPherson, Mary Lynn, PharmD, MA, MDE, BCPS, CPE |
Author_xml | – sequence: 1 fullname: McPherson, Mary Lynn, PharmD, MA, MDE, BCPS, CPE – sequence: 2 fullname: Costantino, Ryan C., PharmD, BCPS, BCGP – sequence: 3 fullname: McPherson, Alexandra L., PharmD, MPH |
BookMark | eNp9kE9LxDAQR4OsYHf1A_ghWidtskkRBFn8B4oH9Tx0JxM2dW0lWYX99qasJw-e5vR-zHtzMRvGgYU4l1BJkMuLvtqMVNUgbQWyAlBHopBa21K2xsxEAda2pdXWnoh5Sj2A1GBVIYon3m06l8dOxbHvtonPfu9CvN3evK7uy8fnu4fV9WNJeUqV7GC9rNfU1opIOWMskXWqZaelbY02HbBtvSelQS0z4htDnhulXdOB9s1CyMMuxTGlyB4_Y_jo4h4l4OSCPWYXnFwQJGaXzFweGM6PfQeOmCjwQOxCZNqhG8O_9NUfmrZhCNRt33nPqR-_4pCNUWKqEfBlajWlkrbJnZRufgBjemYW |
CitedBy_id | crossref_primary_10_1089_jpm_2021_0561 crossref_primary_10_32388_ABG3ZQ crossref_primary_10_3389_fphar_2020_00566 crossref_primary_10_1007_s10143_020_01415_y crossref_primary_10_1097_NJH_0000000000000969 crossref_primary_10_3389_fimmu_2019_02914 crossref_primary_10_1016_j_brainresbull_2022_06_015 crossref_primary_10_32388_ABG3ZQ_2 crossref_primary_10_1093_oncolo_oyab081 crossref_primary_10_1007_s00520_021_06211_y crossref_primary_10_1016_j_ijcrp_2021_200123 crossref_primary_10_4103_0973_1075_285690 |
Cites_doi | 10.1089/jpm.2009.0184 10.1634/theoncologist.2015-0503 10.1016/j.jpainsymman.2015.02.029 10.3109/15360288.2014.938883 10.1089/jpm.2013.0222 10.1185/03007995.2013.840568 10.1111/j.1526-4637.2008.00461.x 10.1089/jpm.2012.0612 10.1089/jpm.2016.0316 10.1089/jpm.2015.0525 10.1089/jpm.2014.0266 10.1089/jpm.2012.0335 10.1016/j.ejpain.2008.01.013 10.1002/chir.10303 |
ContentType | Journal Article |
Copyright | Elsevier Inc. 2018 Elsevier Inc. |
Copyright_xml | – notice: Elsevier Inc. – notice: 2018 Elsevier Inc. |
DBID | AAYXX CITATION |
DOI | 10.1016/j.hoc.2018.01.004 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1558-1977 |
EndPage | 415 |
ExternalDocumentID | 10_1016_j_hoc_2018_01_004 S0889858818300145 1_s2_0_S0889858818300145 |
GroupedDBID | --- .1- .FO .GJ 0R~ 1P~ 34G 39C 4.4 457 4CK 53G 5GY 5RE AAEDT AAEDW AALRI AAQQT AAQXK AAWTL AAXUO ABCQX ABFRF ABJNI ABMAC ABOCM ABPPZ ABQZK ADBBV ADMUD AEFWE AEVXI AFCTW AFFNX AFRHN AFTJW AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AXIYT AZFZN B08 COIAO CS3 DAHGL EBS EJD EX3 F5P FDB FEDTE FGOYB HVGLF HZ~ IH2 J5H N4W O9- OC~ OO- R2- RIG SEL SES TWZ UDS UNMZH WH7 WOW Z5R ZGI ZXP AAIAV AAYXX CITATION |
ID | FETCH-LOGICAL-c1974-ed0b62bc924cc4d778cc8d49ed5189757a0e89ffc45046197f37cfe345d3a05f3 |
ISSN | 0889-8588 |
IngestDate | Fri Aug 23 02:33:13 EDT 2024 Fri Feb 23 02:24:35 EST 2024 Tue Oct 15 22:56:15 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Opioid Cancer pain Methadone Analgesics Pain management |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1974-ed0b62bc924cc4d778cc8d49ed5189757a0e89ffc45046197f37cfe345d3a05f3 |
PageCount | 11 |
ParticipantIDs | crossref_primary_10_1016_j_hoc_2018_01_004 elsevier_sciencedirect_doi_10_1016_j_hoc_2018_01_004 elsevier_clinicalkeyesjournals_1_s2_0_S0889858818300145 |
PublicationCentury | 2000 |
PublicationDate | June 2018 |
PublicationDateYYYYMMDD | 2018-06-01 |
PublicationDate_xml | – month: 06 year: 2018 text: June 2018 |
PublicationDecade | 2010 |
PublicationTitle | Hematology/oncology clinics of North America |
PublicationYear | 2018 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Accessed October 10, 2017. Wallace, Ridley, Bryson (bib16) 2013; 16 Salpeter, Buckley, Buckley (bib18) 2015; 18 Accessed October 8, 2017. Porta-Sales, Garzon-Rodriguez, Villavicencio-Chavez (bib7) 2016; 21 Methadone. Micromedex solutions. Ann Arbor (MI): Truven Health Analytics, Inc. Available at Nova Scotia Health Authority. Using methadone for chronic pain: patient & family guide. 2017. Available at Salpeter, Buckley, Bruera (bib17) 2013; 16 McPherson (bib13) 2016; 17 Weschules, Bain (bib15) 2008; 9 Leavitt (bib25) 2008 Rhondali, Tremellat, Ledoux (bib4) 2013; 16 Neto, Garcia, Garcia (bib3) 2015; 16 U.S. Food & Drug Administration. FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. 2016. Available at Bart, Wyman, Wang (bib10) 2017; 11 Reddy, Schuler, de la Cruz (bib8) 2017; 20 Mercadante, Porzio, Ferrera (bib6) 2008; 12 Good, Afsharimani, Movva (bib1) 2014; 28 Credible Meds. Available at Gerber, Rhodes, Gal (bib5) 2004; 16 Trinkley, Page, Lien (bib11) 2013; 29 Chou, Cruciani, Fiellin (bib9) 2014; 15 McLean, Twomey (bib14) 2015; 50 Accessed October 15, 2017. VA National Pain Management Program. Available at Reddy, Hui, Osta (bib12) 2010; 13 Centers for Disease Control and Prevention (bib2) 2012; 61 Courtemanche, Dao, Gagne (bib19) 2016; 19 Reddy (10.1016/j.hoc.2018.01.004_bib8) 2017; 20 McLean (10.1016/j.hoc.2018.01.004_bib14) 2015; 50 Wallace (10.1016/j.hoc.2018.01.004_bib16) 2013; 16 Neto (10.1016/j.hoc.2018.01.004_bib3) 2015; 16 Salpeter (10.1016/j.hoc.2018.01.004_bib18) 2015; 18 Courtemanche (10.1016/j.hoc.2018.01.004_bib19) 2016; 19 Gerber (10.1016/j.hoc.2018.01.004_bib5) 2004; 16 Salpeter (10.1016/j.hoc.2018.01.004_bib17) 2013; 16 Reddy (10.1016/j.hoc.2018.01.004_bib12) 2010; 13 Leavitt (10.1016/j.hoc.2018.01.004_bib25) 2008 Mercadante (10.1016/j.hoc.2018.01.004_bib6) 2008; 12 Trinkley (10.1016/j.hoc.2018.01.004_bib11) 2013; 29 Centers for Disease Control and Prevention (10.1016/j.hoc.2018.01.004_bib2) 2012; 61 Good (10.1016/j.hoc.2018.01.004_bib1) 2014; 28 10.1016/j.hoc.2018.01.004_bib24 10.1016/j.hoc.2018.01.004_bib21 10.1016/j.hoc.2018.01.004_bib20 Porta-Sales (10.1016/j.hoc.2018.01.004_bib7) 2016; 21 Weschules (10.1016/j.hoc.2018.01.004_bib15) 2008; 9 10.1016/j.hoc.2018.01.004_bib23 10.1016/j.hoc.2018.01.004_bib22 Rhondali (10.1016/j.hoc.2018.01.004_bib4) 2013; 16 Chou (10.1016/j.hoc.2018.01.004_bib9) 2014; 15 McPherson (10.1016/j.hoc.2018.01.004_bib13) 2016; 17 Bart (10.1016/j.hoc.2018.01.004_bib10) 2017; 11 |
References_xml | – volume: 16 start-page: 305 year: 2013 end-page: 309 ident: bib16 article-title: Addition of methadone to another opioid in the management of moderate to severe cancer pain: a case series publication-title: J Palliat Med contributor: fullname: Bryson – volume: 12 start-page: 1040 year: 2008 end-page: 1046 ident: bib6 article-title: Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management publication-title: Eur J Pain contributor: fullname: Ferrera – volume: 19 start-page: 1 year: 2016 end-page: 7 ident: bib19 article-title: Methadone as a coanalgesic for palliative care cancer patients publication-title: J Palliat Med contributor: fullname: Gagne – volume: 17 start-page: 8 year: 2016 end-page: 9 ident: bib13 article-title: Methadone safety guidelines for hospice and palliative care publication-title: AAHPM Quarterly contributor: fullname: McPherson – volume: 16 start-page: 60 year: 2015 end-page: 66 ident: bib3 article-title: Revisiting methadone: pharmacokinetics, pharmacodynamics and clinical indication publication-title: Rev Dor. São Paulo contributor: fullname: Garcia – volume: 50 start-page: 248 year: 2015 end-page: 259 ident: bib14 article-title: Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence publication-title: J Pain Symptom Manage contributor: fullname: Twomey – volume: 20 start-page: 656 year: 2017 end-page: 661 ident: bib8 article-title: Overall survival among cancer patients undergoing opioid rotation to methadone compared to other opioids publication-title: J Palliat Med contributor: fullname: de la Cruz – volume: 15 start-page: 321 year: 2014 end-page: 337 ident: bib9 article-title: Methadone safety: a clinical practice guideline from the American Pain Society and College of Problems on Drug Dependence, in collaboration with the Heart Rhythm Society publication-title: J Pain contributor: fullname: Fiellin – volume: 18 start-page: 114 year: 2015 end-page: 119 ident: bib18 article-title: The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report publication-title: J Palliat Med contributor: fullname: Buckley – volume: 28 start-page: 197 year: 2014 end-page: 205 ident: bib1 article-title: Therapeutic challenges in cancer pain management: a systematic review of methadone publication-title: J Pain Palliat Care Pharmacother contributor: fullname: Movva – year: 2008 ident: bib25 article-title: Methadone safety handout for patients contributor: fullname: Leavitt – volume: 21 start-page: 981 year: 2016 end-page: 987 ident: bib7 article-title: Efficacy and safety of methadone as a second-line opioid for cancer pain in an outpatient clinic: a prospective open-label study publication-title: Oncologist contributor: fullname: Villavicencio-Chavez – volume: 16 start-page: 1 year: 2013 end-page: 7 ident: bib17 article-title: The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia publication-title: J Palliat Med contributor: fullname: Bruera – volume: 61 start-page: 493 year: 2012 end-page: 497 ident: bib2 article-title: Vital signs: risk for overdose from methadone used for pain relief – United States, 1999-2010 publication-title: MMWR Morb Mortal Wkly Rep contributor: fullname: Centers for Disease Control and Prevention – volume: 16 start-page: 36 year: 2004 end-page: 44 ident: bib5 article-title: Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19 publication-title: Chirality contributor: fullname: Gal – volume: 29 start-page: 1719 year: 2013 end-page: 1726 ident: bib11 article-title: QT interval prolongation and the risk of torsades de pointes: essentials for clinicians publication-title: Curr Med Res Opin contributor: fullname: Lien – volume: 16 start-page: 1382 year: 2013 end-page: 1387 ident: bib4 article-title: Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study publication-title: J Palliat Med contributor: fullname: Ledoux – volume: 9 start-page: 595 year: 2008 end-page: 612 ident: bib15 article-title: A systematic review of opioid conversion ratios used with methadone for the treatment of pain publication-title: Pain Med contributor: fullname: Bain – volume: 11 start-page: 489 year: 2017 end-page: 493 ident: bib10 article-title: Methadone and the QTc interval: paucity of clinically significant factors in a retrospective cohort publication-title: J Addict Med contributor: fullname: Wang – volume: 13 start-page: 33 year: 2010 end-page: 38 ident: bib12 article-title: The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study publication-title: J Palliat Med contributor: fullname: Osta – volume: 13 start-page: 33 issue: 1 year: 2010 ident: 10.1016/j.hoc.2018.01.004_bib12 article-title: The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study publication-title: J Palliat Med doi: 10.1089/jpm.2009.0184 contributor: fullname: Reddy – volume: 21 start-page: 981 year: 2016 ident: 10.1016/j.hoc.2018.01.004_bib7 article-title: Efficacy and safety of methadone as a second-line opioid for cancer pain in an outpatient clinic: a prospective open-label study publication-title: Oncologist doi: 10.1634/theoncologist.2015-0503 contributor: fullname: Porta-Sales – ident: 10.1016/j.hoc.2018.01.004_bib21 – volume: 50 start-page: 248 issue: 2 year: 2015 ident: 10.1016/j.hoc.2018.01.004_bib14 article-title: Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence publication-title: J Pain Symptom Manage doi: 10.1016/j.jpainsymman.2015.02.029 contributor: fullname: McLean – ident: 10.1016/j.hoc.2018.01.004_bib23 – volume: 28 start-page: 197 year: 2014 ident: 10.1016/j.hoc.2018.01.004_bib1 article-title: Therapeutic challenges in cancer pain management: a systematic review of methadone publication-title: J Pain Palliat Care Pharmacother doi: 10.3109/15360288.2014.938883 contributor: fullname: Good – volume: 16 start-page: 1382 issue: 11 year: 2013 ident: 10.1016/j.hoc.2018.01.004_bib4 article-title: Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study publication-title: J Palliat Med doi: 10.1089/jpm.2013.0222 contributor: fullname: Rhondali – volume: 16 start-page: 60 issue: 1 year: 2015 ident: 10.1016/j.hoc.2018.01.004_bib3 article-title: Revisiting methadone: pharmacokinetics, pharmacodynamics and clinical indication publication-title: Rev Dor. São Paulo contributor: fullname: Neto – volume: 29 start-page: 1719 issue: 12 year: 2013 ident: 10.1016/j.hoc.2018.01.004_bib11 article-title: QT interval prolongation and the risk of torsades de pointes: essentials for clinicians publication-title: Curr Med Res Opin doi: 10.1185/03007995.2013.840568 contributor: fullname: Trinkley – volume: 9 start-page: 595 issue: 5 year: 2008 ident: 10.1016/j.hoc.2018.01.004_bib15 article-title: A systematic review of opioid conversion ratios used with methadone for the treatment of pain publication-title: Pain Med doi: 10.1111/j.1526-4637.2008.00461.x contributor: fullname: Weschules – volume: 16 start-page: 1 issue: 6 year: 2013 ident: 10.1016/j.hoc.2018.01.004_bib17 article-title: The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia publication-title: J Palliat Med doi: 10.1089/jpm.2012.0612 contributor: fullname: Salpeter – volume: 17 start-page: 8 issue: 2 year: 2016 ident: 10.1016/j.hoc.2018.01.004_bib13 article-title: Methadone safety guidelines for hospice and palliative care publication-title: AAHPM Quarterly contributor: fullname: McPherson – ident: 10.1016/j.hoc.2018.01.004_bib24 – volume: 20 start-page: 656 year: 2017 ident: 10.1016/j.hoc.2018.01.004_bib8 article-title: Overall survival among cancer patients undergoing opioid rotation to methadone compared to other opioids publication-title: J Palliat Med doi: 10.1089/jpm.2016.0316 contributor: fullname: Reddy – ident: 10.1016/j.hoc.2018.01.004_bib20 – volume: 11 start-page: 489 issue: 6 year: 2017 ident: 10.1016/j.hoc.2018.01.004_bib10 article-title: Methadone and the QTc interval: paucity of clinically significant factors in a retrospective cohort publication-title: J Addict Med contributor: fullname: Bart – volume: 19 start-page: 1 issue: 9 year: 2016 ident: 10.1016/j.hoc.2018.01.004_bib19 article-title: Methadone as a coanalgesic for palliative care cancer patients publication-title: J Palliat Med doi: 10.1089/jpm.2015.0525 contributor: fullname: Courtemanche – ident: 10.1016/j.hoc.2018.01.004_bib22 – volume: 61 start-page: 493 year: 2012 ident: 10.1016/j.hoc.2018.01.004_bib2 article-title: Vital signs: risk for overdose from methadone used for pain relief – United States, 1999-2010 publication-title: MMWR Morb Mortal Wkly Rep contributor: fullname: Centers for Disease Control and Prevention – volume: 18 start-page: 114 issue: 2 year: 2015 ident: 10.1016/j.hoc.2018.01.004_bib18 article-title: The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report publication-title: J Palliat Med doi: 10.1089/jpm.2014.0266 contributor: fullname: Salpeter – year: 2008 ident: 10.1016/j.hoc.2018.01.004_bib25 contributor: fullname: Leavitt – volume: 16 start-page: 305 issue: 3 year: 2013 ident: 10.1016/j.hoc.2018.01.004_bib16 article-title: Addition of methadone to another opioid in the management of moderate to severe cancer pain: a case series publication-title: J Palliat Med doi: 10.1089/jpm.2012.0335 contributor: fullname: Wallace – volume: 12 start-page: 1040 year: 2008 ident: 10.1016/j.hoc.2018.01.004_bib6 article-title: Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management publication-title: Eur J Pain doi: 10.1016/j.ejpain.2008.01.013 contributor: fullname: Mercadante – volume: 15 start-page: 321 year: 2014 ident: 10.1016/j.hoc.2018.01.004_bib9 article-title: Methadone safety: a clinical practice guideline from the American Pain Society and College of Problems on Drug Dependence, in collaboration with the Heart Rhythm Society publication-title: J Pain contributor: fullname: Chou – volume: 16 start-page: 36 issue: 16 year: 2004 ident: 10.1016/j.hoc.2018.01.004_bib5 article-title: Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19 publication-title: Chirality doi: 10.1002/chir.10303 contributor: fullname: Gerber |
SSID | ssj0015084 |
Score | 2.2321973 |
SecondaryResourceType | review_article |
Snippet | Methadone is a valuable opioid in the management of patients who have cancer with pain. Methadone is a mu-, kappa-, and delta-opioid agonist, and an N-methyl-... Methadone is a valuable opioid in the management of patients who have cancer with pain. Methadone is a mu-, kappa-, and delta-opioid agonist, and an... |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | 405 |
SubjectTerms | Analgesics Cancer pain Hematology, Oncology, and Palliative Medicine Methadone Opioid Pain management |
Title | Methadone |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0889858818300145 https://dx.doi.org/10.1016/j.hoc.2018.01.004 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LaxsxEBZOCm0voU_qPEoOOdXIaHclS3tM1k4NicOSpFB6EbuSFjcHu2Sdg_99RtI-vHlAW8hFGLF6zI48-81oHggdMaZDwwOGwziPMDXxCOcCGmbVj1FuCM-c6eKKX_wU4wmd9Hp1MZ2270U5DX3Aaxs5-w_cbiaFDvgNPIcWuA7tX_F9ZlbzTC8XHRefqc3MWsWlnC4Xyide8lGRzpejc33T2urSuQPkVVDPenC-9nA3tQmvx6772LVj51R5kqTOEzBJ2_iGpYWfq9-uwvfgcg3iJBl2p6hHnSTf0yeXroJwbrPB-YOhs3S6abYIROte1Ui3GAvma_rVorg1dbaaupOrlLCNTzT1EaCPpL83RNwM50ubnDIQLiGrr27czbQ9Sc4CXIZDgq_sPuw2QLRZdZF1H_Z6kixDSeSjR7fQqxDEm63Y8ItdNndXAHmp1108gfVduvMqfLC1p9HQBsK5fod2KtXk8NifqfeoZxYf0OtZ5XzxEb1pjtYn9ON0cp1McVVJA6sAFEZsNMlHYa5A2VaKas6FUkLT2GgWiJgznhEj4qJQlNkE_DEvIq4KE1Gmo4ywIvqMthcw_Rd0CNQHOdFhbDIL9q3CbK1iGoCQAlU67KNvNUXyj0-YImtPwhsJ5EtLviSBBPL7iNc0yzoSGL5dpqz-UKV87t33EW1GVljRY0AJh-H5BXf_e8E99LY9xvtoe3V7Zw7QVqnvvjr23wNtrXun |
link.rule.ids | 315,782,786,27934,27935 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Methadone&rft.jtitle=Hematology%2Foncology+clinics+of+North+America&rft.au=McPherson%2C+Mary+Lynn%2C+PharmD%2C+MA%2C+MDE%2C+BCPS%2C+CPE&rft.au=Costantino%2C+Ryan+C.%2C+PharmD%2C+BCPS%2C+BCGP&rft.au=McPherson%2C+Alexandra+L.%2C+PharmD%2C+MPH&rft.date=2018-06-01&rft.issn=0889-8588&rft.volume=32&rft.issue=3&rft.spage=405&rft.epage=415&rft_id=info:doi/10.1016%2Fj.hoc.2018.01.004&rft.externalDBID=ECK1-s2.0-S0889858818300145&rft.externalDocID=1_s2_0_S0889858818300145 |
thumbnail_m | http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F08898588%2FS0889858818X00033%2Fcov150h.gif |